January 5, 2017 / 12:32 PM / 9 months ago

BUZZ-U.S. STOCKS ON THE MOVE-Macy's, Kohl's, CTI Biopharma, Heron

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, here ; for the Morning News Call newsletter, here ) U.S. stock index futures were flat on Thursday, a day after Federal Reserve minutes showed policymakers thought President-elect Donald Trump's pro-growth policies could prompt faster interest rate hikes.

Dow Jones industrial average futures were down 0.09 percent at 19,839, S&P 500 futures were down 0.17 percent at 2,260.5 and Nasdaq 100 futures were down 0.20 percent at 4,923.5.

** MACY‘S INC, Wednesday close $35.84, -10.16 pct premarket

** KOHL‘S CORP, Wednesday close $51.88, -15.19 pct premarket

The department store chains cut their 2016 profit forecasts, after holiday season sales fell more than expected.

** FORD MOTOR CO, Wednesday close $13.17

** AMAZON.COM INC, Wednesday close $757.18, -0.03 pct premarket

Ford is expanding the use of Amazon.com’s Alexa personal assistant in its vehicles to allow drivers to talk to their cars - demanding anything from a nearby cheeseburger to a weather forecast - marking a leap by the Detroit automaker to incorporate a technology initially targeted for home use.

** CTI BIOPHARMA CORP, Wednesday close $3.97, +29.22 pct premarket

The drug developer said the U.S. FDA has removed full clinical hold on its experimental blood cancer drug, pacritinib.

** ALEXION PHARMACEUTICALS INC, Wednesday close $127.11, +4.63 pct premarket

The drugmaker see no need to restate previously issued results, following an investigation related to sales practices of its blood disorder drug, Soliris.

** CESCA THERAPEUTICS INC, Wednesday close $3.67, +14.44 pct premarket

The company announced FDA approval of IDE supplement for Phase III clinical trial.

** AETERNA ZENTARIS INC, Wednesday close $3.65, -35.62 pct premarket

The Canadian drug developer’s experimental test to diagnose adult growth hormone deficiency (AGHD) failed late-stage study.

** HERON THERAPEUTICS INC, Wednesday close $13.8, -11.59 pct premarket

Heron on Wednesday said its experimental combination drug for post-operative pain led to significant reductions in pain intensity and the need for opioids, according to initial data from a mid-stage trial.

At least two brokerages cut their price targets on the stock.

** NEW YORK TIMES CO, Wednesday close $13.7

Apple has removed the New York Times news apps from its app store in China following a request from the Chinese authorities, the companies said separately. (Compiled by Rishika Sadam in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below